2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$0.65+$0.02 (+3.32%)
Price as of Nov 11, 2026 7:30 PM EST- $38.0MMarket Cap
- -87.97%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$0.65+$0.02 (+3.32%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.63 | ||
Change | -$0.007 (-1.08%) | ||
Open | $0.60 | ||
High | $0.64 | ||
Low | $0.58 | ||
Previous Close | $0.64 | ||
Volume | 418,043 | ||
30-Day Average Volume | 961,175 | ||
1-Week Change | 1.37% | ||
1-Month Change | -31.34% | ||
1-Year Change | -87.97% | ||
3-Year Change | -72.47% | ||
5-Year Change | -93.08% | ||
Fundamentals | |||
Shares Outstanding | 60.4M | ||
Total Assets | $43.4M | ||
Market Cap | $38.0M | ||
Enterprise Value | $42.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.8M | ||
Free Cash Flow | -$4.1M | ||
EBIT | -$3.8M | ||
EBITDA | -$3.6M | ||
Net Working Capital | $35.0M | ||
EPS | -$0.06 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue